Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2002 May;93(5):567–573. doi: 10.1111/j.1349-7006.2002.tb01292.x

Inhibition of Nucleotide Excision Repair by Fludarabine in Normal Lymphocytes in vitro, Measured by the Alkaline Single Cell Gel Electrophoresis (Comet) Assay

Takahiro Yamauchi 1,✉, Yasukazu Kawai 1, Takanori Ueda 1
PMCID: PMC5927026  PMID: 12036453

Abstract

Alkylating agents or platinum analogues initiate several excision repair mechanisms, which involve incision of the DNA strand, excision of the damaged nucleotide, gap filling by DNA resynthesis, and rejoining by ligation. The previous study described that nucleotide excision repair permitted incorporation of fludarabine nucleoside (F‐ara‐A) into the repair patch, thereby inhibiting the DNA resynthesis. In the present study, to clarify the repair kinetics in view of the inhibition by F‐ara‐A, normal lymphocytes were stimulated to undergo nucleotide excision repair by ultraviolet C (UV) irradiation in the presence or absence of F‐ara‐A. The repair kinetics were determined as DNA single strand breaks resulting from the incision and the rejoining using the alkaline single cell gel electrophoresis (comet) assay. DNA resynthesis was evaluated in terms of the uptake of tritiated thymidine into DNA. The lymphocytes initiated the incision step maximally at 1 h, and completed the rejoining process within 4 h after UV exposure. UV also initiated thymidine uptake, which increased time‐dependently and reached a plateau at 4 h. A 2–h pre‐incubation with F‐ara‐A inhibited the repair in a concentration‐dependent manner, with the maximal inhibition by 5 μM. This inhibitory effect was demonstrated by the reduction of the thymidine uptake and by the inhibition of the rejoining. A DNA polymerase inhibitor, aphidicolin, and a ribonucleotide reductase inhibitor, hydroxyurea, were not so inhibitory to the repair process as F‐ara‐A at equimolar concentrations. The present findings suggest that inhibition of nucleotide excision repair may represent a novel therapeutic strategy against cancer, especially in the context of resistant cells with an increased repair capacity.

Keywords: DNA damage, DNA repair, Drug resistance, Nucleoside analogue, Comet assay

Full Text

The Full Text of this article is available as a PDF (519.1 KB).

REFERENCES

  • 1. ) Yamauchi , T. , Tsutani , H. , Nakayama , T. , Imamura , S. , Inai , K. , Wataya , S. , Tanaka , T. , Yoshida , A. , Iwasaki , H. , Fukushima , T. , Tohyama , K. , Wano , Y. , Ueda , T. and Nakamura , T.Carboplatin treatment by continuous infusion in combination for relapsed and refractory acute myeloid leukemia . Jpn. J. Cancer Chemother. , 21 , 2843 – 2847 ( 1994. ). [PubMed] [Google Scholar]
  • 2. ) Tew , K. D. , Colvin , M. and Chabner , B. A.Alkylating agents . In “ Cancer Chemotherapy and Biotherapy ,” ed. Chabner B. A. and Longo D. L. , pp. 297 – 317 ( 1996. ). Lippincott‐Raven Publ. , Philadelphia . [Google Scholar]
  • 3. ) Ogura , M.Recent progress in the treatment of malignant lymphoma . Jpn. J. Cancer Chemother. , 28 , 1213 – 1235 ( 2001. ). [PubMed] [Google Scholar]
  • 4. ) Kobrinsky , N. L. , Sposto , R. , Shah , N. R. , Anderson , J. R. , DeLaat , C. , Morse , M. , Warkentin , P. , Gilchrist , G. S. , Cohen , M. D. , Shina , D. and Meadows , A. T.Outcomes of treatment of children and adolescents with recurrent non‐Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l‐asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG–5912 . J. Clin. Oncol. , 19 , 2390 – 2396 ( 2001. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Pinto , A. L. and Lippard , S. J.Binding of the antitumor drug cis‐diamminedichloroplatinum (II) (cisplatin) to DNA . Biochim. Biophys. Acta , 780 , 167 – 180 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Povirk , L. F. and Shuker , D. E.DNA damage and mutagenesis induced by nitrogen mustards . Mutat. Res. , 318 , 205 – 226 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Geleziunas , R. , McQuillan , A. , Malapetsa , A. , Hutchinson , M. , Kopriva , D. , Wainberg , M. A. , Hiscott , J. , Bramson , J. and Panasci , L.Increased DNA synthesis and repair‐enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards . J. Natl. Cancer Inst. , 83 , 557 – 564 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Chaney , S. G. and Sancar , A.DNA repair: enzymatic mechanisms and relevance to drug response . J. Natl. Cancer Inst. , 88 , 1346 – 1360 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Panasci , L. , Paiement , J.‐P. , Christodoulopoulos , G. , Belenkov , A. , Malapetsa , A. and Aloyz , R.Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair . Clin. Cancer Res. , 7 , 454 – 461 ( 2001. ). [PubMed] [Google Scholar]
  • 10. ) Wood , R. D.DNA repair in eukaryotes . Annu. Rev. Biochem. , 65 , 135 – 167 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Sancar , A.DNA excision repair . Annu. Rev. Biochem. , 65 , 43 – 81 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Lindahl , T. and Wood , R. D.Quality control by DNA repair . Science , 286 , 1897 – 1905 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Thompson , L. H.18 Nucleotide excision repair . In “ DNA Damage and Repair, Vol. 2: DNA Repair in Higher Eukaryotes ,” ed. Nickoloff J. A. and Hoekstra M. F. , pp. 335 – 393 ( 1998. ). Humana Press, Inc. , Totowa . [Google Scholar]
  • 14. ) Keating , M. J. , O'Brien , S. , Lerner , S. , Koller , C. , Beran , M. , Robertson , L. E. , Freireich , E. J. , Estey , E. and Kantarjian , H.Long‐term follow‐up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy . Blood , 92 , 1165 – 1171 ( 1998. ). [PubMed] [Google Scholar]
  • 15. ) Gandhi , V. , Estey , E. , Du , M. , Keating , M. J. and Plunkett , W.Minimum dose of fludarabine for the maximal modulation of 1–beta‐d‐arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy . Clin. Cancer Res. , 3 , 1539 – 1545 ( 1997. ). [PubMed] [Google Scholar]
  • 16. ) Huang , P. , Chubb , S. and Plunkett , W.Termination of DNA synthesis by 9–β‐d‐arabinofuranosyl–2–fluoroadenine. A mechanism for cytotoxicity . J. Biol. Chem. , 265 , 16617 – 16625 ( 1990. ). [PubMed] [Google Scholar]
  • 17. ) Yang , S. W. , Huang , P. , Plunkett , W. , Becker , F. F. and Chan , J. Y.Dual mode of inhibition of purified DNA ligase I from human cells by 9–β–d‐arabinofuranosyl–2–fluoroadenine triphosphate . J. Biol. Chem. , 267 , 2345 – 2349 ( 1992. ). [PubMed] [Google Scholar]
  • 18. ) Plunkett , W. , Gandhi , V. , Huang , P. , Robertson , L. E. , Yang , L.‐Y. , Gregoire , V. , Estey , E. and Keating , M. J.Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies . Semin. Oncol. , 20 , 2 – 12 ( 1993. ). [PubMed] [Google Scholar]
  • 19. ) Huang , P. and Plunkett , W.Fludarabine‐ and gemcitabine‐induced apoptosis: incorporation of analogs into DNA is a critical event . Cancer Chemother. Pharmacol. , 36 , 181 – 188 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Tseng , W.‐C. , Derse , D. , Cheng , Y.‐C. , Brockman , R. W. and Bennett , L. L.In vitro biological activity of 9–β–d‐ara‐binofuranosyl–2–fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells . Mol. Pharmacol. , 21 , 474 – 477 ( 1982. ). [PubMed] [Google Scholar]
  • 21. ) Sandoval , A. , Consoli , U. and Plunkett , W.Fludarabine‐mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes . Clin. Cancer Res. , 2 , 1731 – 1741 ( 1996. ). [PubMed] [Google Scholar]
  • 22. ) Fairbairn , D. W. , Olive , P. L. and O'Neill , K. L.The comet assay: a comprehensive review . Mutat. Res. , 339 , 37 – 59 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Singh , N. P. , McCoy , M. T. , Tice , R. R. and Schneider , E. L.A simple technique for quantitation of low levels of DNA damage in individual cells . Exp. Cell Res. , 175 , 184 – 191 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Tice , R. R. , Agurell , E. , Anderson , D. , Burlinson , B. , Hartmann , A. , Kobayashi , H. , Miyamae , Y. , Rojas , E. , Ryu , J.‐C. and Sasaki , Y. F.Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing . Environ. Mol. Mutagen. , 35 , 206 – 221 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Evans , R. G. and Norman , A.Unscheduled incorporation of thymidine in ultraviolet‐radiated human lymphocytes . Radiat. Res. , 36 , 287 – 298 ( 1968. ). [PubMed] [Google Scholar]
  • 26. ) Miller , M. R. and Chinault , D. N.The roles of DNA polymerases α, β, and γ in DNA repair synthesis induced in hamster and human cells by different DNA damaging agents . J. Biol. Chem. , 257 , 10204 – 10209 ( 1982. ). [PubMed] [Google Scholar]
  • 27. ) Collins , A. and Oates , D. J.Hydroxyurea: effects on deoxyribonucleotide pool sizes correlated with effects on DNA repair in mammalian cells . Eur. J. Biochem. , 169 , 299 – 305 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Fallon , H. J. , Frei , E. , III , Davidson , J. D. , Trier , J. S. and Burk , D.Leukocyte preparations from human blood: evaluation of their morphologic and metabolic state . J. Lab. Clin. Med. , 59 , 779 – 791 ( 1962. ). [PubMed] [Google Scholar]
  • 29. ) Olive , P. L. , Banath , J. P. and Durand , R. E.Heterogeneity in radiation‐induced DNA damage and repair in tumor and normal cells measured using the “comet” assay . Radiat. Res. , 122 , 86 – 94 ( 1990. ). [PubMed] [Google Scholar]
  • 30. ) Kawai , Y. and Plunkett , W.DNA repair induced by 4–hydroperoxycyclophosphamide permits fludarabine nucleotide incorporation and is associated with synergistic induction of apoptosis in quiescent human lymphocytes . Blood , 94 , 655a ( 1999. ). [Google Scholar]
  • 31. ) Hibino , Y. , Hiraoka , Y. , Kamiuchi , S. , Kusashio , E. and Sugano , N.Enhancement of excision repair of cisplatin‐DNA adducts by cell‐free extract from a cisplatin‐resistant rat cell line . Biochem. Pharmacol. , 57 , 1415 – 1422 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Martin , F. L. , Cole , K. J. , Orme , M. H. , Grover , P. L. , Phillips , D. H. and Venitt , S.The DNA repair inhibitors hydroxyurea and cytosine arabinoside enhance the sensitivity of the alkaline single‐cell gel electrophoresis (‘comet’) assay in metabolically‐competent MCL–5 cells . Mutat. Res. , 445 , 21 – 43 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Yamauchi , T. , Nowak , B. J. , Keating , M. J. and Plunkett , W.DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4–hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine . Clin. Cancer Res. , 7 , 3580 – 3589 ( 2001. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES